Corporate Governance
In accordance with AIM Rule 26, Silence Therapeutics plc offers the following information:
Countries of Registration:
England and WalesCompany Registered Number:
2992058Location of Operations:
Silence is headquartered in the U.K. with research and development operations carried out in Germany.Nominated Advisors and Brokers:
Singer Capital Markets Limited 1 Hanover Street London W1S 1YZ Tel: +44 20 3205 7500Constitutional Documents:
Most Recent AIM Admission Document- Summary of Articles
- Memorandum of Association
- Full Articles of Association
Disclosure Forms:
Meeting Notification and Proxy:
Annual and Interim Reports:
Recent Circulars:
Fundraising Presentations:
Committee Composition:
Remuneration Committee – Assisting the board in the discharging of its responsibilities related to remuneration of the company’s executive officers.
- Annette Clancy (Chairman)
- Jerry Randall
- David Mack
Audit Committee – Assisting board oversight of accounting and financial reporting processes and the audits of the company’s financial statements
- Jerry Randall (Chairman)
Nominations and Governance Committee – Recommending to the board those persons to be nominated for election as directors at any shareholders meeting
- Annette Clancy
- David Mack
Major Shareholdings
As at 31 March 2012 the Company had been informed of the following substantial interests of over 3% of the issued share capital of the Company:| Name | Number | Percentage of Issued Share Capital |
|---|---|---|
| Robert Keith* | 54,089,628 | 9.37% |
| Hedger Management | 50,000,000 | 8.66% |
| Frazier Healthcare Ventures | 27,265,465 | 4.72% |
| Richard Bernstein | 26,515,000 | 4.59% |
| Southern Fox Investments | 26,173,913 | 4.54% |
| ACP Capital | 25,356,422 | 4.39% |
| Simpson Financial | 25,000,000 | 4.33% |
| Walker Crips Stockbrokers | 24,257,101 | 4.20% |
| In addition to the direct holdings above Robert Keith has an indirect interest in a further 13m shares | ||